1 Product identity

Bromelain

BrandDaVinci Laboratories Of VermontNon-Nutrient/Non-Botanical Tablet or Pill 9 ingredients DSLD #21899
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-05-24
2 Ingredients (9)
IngredientGroupSafety
BromelainBromelainConditionally Safe
Microcrystalline CelluloseCellulose
Stearic AcidStearic Acid
Croscarmellose SodiumCroscarmellose SodiumConditionally Safe
Vegetable StearateMagnesium stearate
Silicon DioxideSiliconGenerally Safe
hydroxypropyl methylcellulose phthalateHypromellose
TalcMagnesium Silicate
Titanium DioxideTitanium DioxideLimited Evidence
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Bromelain — Conditionally Safe
⚠ Increased bleeding risk
⚠ GI upset
Sodium — Conditionally Safe
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Titanium Dioxide — Limited Evidence
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID21899
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-05-24
6 More from DaVinci Laboratories Of Vermont
View DaVinci Laboratories Of Vermont Safety Scorecard → 80 products
Alpha Lipoic Acid 100 mgBeauty & BrainsBilberryCalcium Citrate PlusCartilage+Celadrin With HA
7 Cite this page
Vancouver
Pkhakadze G. Bromelain — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 02]. Available from: https://supplement.ge/products/bromelain-21899/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG